Publications:  Dr Samir Agrawal

Aries JA, Davies JK, Auer RL, Hallam SL, Montoto S, Smith M, Sevillano B, Foggo V et al.(2020). Clinical Outcome of Coronavirus Disease 2019 in Haemato-oncology Patients. British Journal of Haematology

Muhsen IN, Hashmi SK, Niederwieser D, Kroeger N, Agrawal S, Pasquini MC, Atsuta Y, Ballen KK et al.(2020). Correction: Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries. Bone Marrow Transplant vol. 55, (4)

Muhsen IN, Hashmi SK, Niederwieser D, Kroeger N, Agrawal S, Pasquini MC, Atsuta Y, Ballen KK et al.(2020). Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries. Bone Marrow Transplant vol. 55, (4) 698-707.

Wang HQ, Jia L, Li YT, Farren T, Agrawal SG, Liu FT(2019). Increased autocrine interleukin-6 production is significantly associated with worse clinical outcome in patients with chronic lymphocytic leukemia. Journal of Cellular Physiology vol. 234, (8) 13994-14006.

Schelenz S, Owens K, Guy R, Rautemaa-Richardson R, Manuel RJ, Richardson M, Moore C, Enoch DA et al.(2019). National mycology laboratory diagnostic capacity for invasive fungal diseases in 2017: Evidence of sub-optimal practice. J Infect

Agrawal SG, Pfeffer PE, Lewis White P(2019). 13th Annual Fungal Update Conference. Medical Mycology vol. 57, S257-S258.

Agrawal S, Vamadevan P, Mazibuko N, Bannister R, Swery R, Wilson S, Edwards S(2019). A New Method for Ethical and Efficient Evidence Generation for Off-Label Medication Use in Oncology (A Case Study in Glioblastoma). Front Pharmacol vol. 10,

Clear AJ, D'Avola A, Agrawal SG, Rassenti LZ, Kipps TJ, Gribben JG, Riches J (2018). B-Cell Receptor Signaling Drives Glycolysis in Chronic Lymphocytic Leukemia Cells. BLOOD. vol. 132,

Agrawal S, Mathieson N, Krendyukov A (2018). Sandoz biosimilar filgrastim in stem cell mobilization - a decade of clinical experience. BONE MARROW TRANSPLANTATION. vol. 53, 785-786.

Micallef C, Ashiru-Oredope D, Hansraj S, Denning DW, Agrawal SG, Manuel RJ, Schelenz S, Guy R et al.(2017). An investigation of antifungal stewardship programmes in England. J Med Microbiol vol. 66, (11) 1581-1589.

Cornely OA, Leguay T, Maertens J, Vehreschild MJGT, Anagnostopoulos A, Castagnola C, Verga L, Rieger C et al.(2017). Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia. Journal of Antimicrobial Chemotherapy vol. 72, (8) 2359-2367.

Taylor JG, Seddon T, Alizadeh K, Agrawal C, Kempster L, Gribben JG, Agrawal SG (2017). Single centre experience of ZarzioTM biosimilar Granulocyte-colony stimulating factor (GCSF) for the mobilisation of healthy donors demonstrates good leukapheresis yields and safety profile at 24 month median follow-up. BONE MARROW TRANSPLANTATION. vol. 52, S145-S146.

Tissot F, Agrawal S, Pagano L, Petrikkos G, Groll AH, Skiada A, Lass-Flörl C, Calandra T et al.(2016). ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients. Haematologica vol. 102, (3) 433-444.

Jones BL, Richardson MD, Ingram PM, Agrawal SG(2016). A CONSORT analysis of randomised controlled trials for the treatment of invasive aspergillosis. Medical Mycology

Nannini F, Parekh F, Jakubowska A, Akarca A, Marafioti T, Chester K, Onuoha S, Agrawal SG et al. (2016). Development of novel anti-CD160 CARs. vol. 27, is. 11, pp. A85-A85.

Agrawal S, Barnes R, Brüggemann RJ, Rautemaa-Richardson R, Warris A(2016). The role of the multidisciplinary team in antifungal stewardship. J Antimicrob Chemother vol. 71, (suppl 2) ii37-ii42.

Choudhury T, Mozid A, Hamshere S, Yeo C, Pellaton C, Arnous S, Saunders N, Brookman P et al.(2016). An exploratory randomized control study of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with ischaemic cardiomyopathy: the REGENERATE-IHD clinical trial. European Journal of Heart Failure vol. 19, (1) 138-147.

Liu FT, Jia L, Wang P, Farren T, Li H, Hao X, Agrawal SG(2016). CD126 and targeted therapy with tocilizumab in chronic lymphocytic leukemia. Clinical Cancer Research vol. 22, (10) 2462-2469.

Liu F-T, Jia L, Wang P, Wang H, Farren TW, Agrawal SG(2016). STAT3 and NF-κB cooperatively control <i>in vitro</i> spontaneous apoptosis and poor chemo-responsiveness in patients with chronic lymphocytic leukemia. Oncotarget

Choudry F, Hamshere S, Saunders N, Veerapen J, Bavnbek K, Knight C, Pellerin D, Locca D et al.(2016). A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: The REGENERATE-AMI clinical trial. European Heart Journal vol. 37, (3) 256-263.

Halperin D, Hallam S, Haroon A, Butler T, Agrawal S(2016). Bing-Neel Syndrome Case Report: A Previously Undocumented IgG Variant with MRI, PET/CT, and PET/MRI Imaging. Case Rep Hematol vol. 2016,

Hamshere S, Arnous S, Choudhury T, Choudry F, Mozid A, Yeo C, Barrett C, Saunders N et al.(2015). Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial. EUROPEAN HEART JOURNAL vol. 36, (44) 3061-3069.

Agrawal SG, Dexter TL (2015). Cost of antifungal drugs in different haemato-oncology settings. MYCOSES. vol. 58, 157-158.

Agrawal SG (2015). INVASIVE FUNGAL DISEASE MANAGEMENT IN HAEMATO-ONCOLOGY. LEUKEMIA RESEARCH. vol. 39, SS10-SS10.

Bustin SA, Thornton CR, Shannon M, Agrawal SG, Lass-Floerl C, Mutschlechner W, Roberts D, Johnson G (2015). Immuno PCR-based assays for the early detection of Aspergillus species. MYCOSES. vol. 58, 28-28.

Johnson GL, Taylor E, Weddell A, Agrawal C, Ready D, Tiberi S, Wyllie S, Sarker SJ et al.(2015). TRIADx: A comprehensive and rapid invasive aspergillosis diagnostic testing service for real-time patient management. MYCOSES vol. 58, 103-104.

Johnson GL, Sarker SJ, Nannini F, Ferrini A, Taylor E, Lass-Flörl C, Mutschlechner W, Bustin SA et al.(2015). Aspergillus-specific lateral-flow device and real-time PCR testing of bronchoalveolar lavage fluid: A combination biomarker approach for clinical diagnosis of invasive pulmonary aspergillosis. Journal of Clinical Microbiology vol. 53, (7) 2103-2108.

Quinn J, Todd S, Agrawal S, Tsitsikas DA(2015). A curious case of facial swelling in the night-time. BMJ vol. 350,

Desai N, Nannini F, Agrawal SG (2015). Investigating differences in serum and plasma values in galactomannan testing, signal loss and sources of false positivity. BRITISH JOURNAL OF HAEMATOLOGY. vol. 169, 77-77.

Wang P, Wang P, Liu B, Zhao J, Pang Q, Agrawal SG, Jia L, Liu FT(2015). Dynamin-related protein Drp1 is required for Bax translocation to mitochondria in response to irradiation-induced apoptosis. Oncotarget vol. 6, (26) 22598-22612.

Farren TW, Giustiniani J, Fanous M, Liu F, Macey MG, Wright F, Prentice A, Nathwani A et al.(2015). Minimal residual disease detection with tumor-specific CD160 correlates with event-free survival in chronic lymphocytic leukemia. Blood Cancer Journal vol. 5, (1)

Hamshere S, Arnous S, Choudhury T, Choudry F, Mozid A, Yeo C, Barrett C, Saunders N et al.(2015). Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: The REGENERATEDCM clinical trial. European Heart Journal vol. 36, (44) 3061-3069.

Uddin S, Russell P, Farrell M, Davy B, Taylor J, Agrawal SG(2015). Use of biosimilar filgrastim compared with lenograstim in autologous haematopoietic stem-cell transplant and in sibling allogeneic transplant. Therapeutic Advances in Hematology vol. 6, (2) 53-60.

Cornely O, Leguay T, Maertens J, Castagnola C, Anagnostopoulos A, Allione B, Heussel CP, Donnelly JP et al. (2014). A Double-Blind, Multicentre, Randomised, Placebo-Controlled Study to Assess the Efficacy, Safety and Tolerability of Prophylactic Liposomal Amphotericin B (AmBisome (R)) for the Prevention of Invasive Fungal Infections in Subjects Receiving Remission-Induction Chemotherapy for Acute Lymphoblastic Leukaemia (AmBiGuard trial). BLOOD. vol. 124,

Farren TW, Liu F, Le Garff-Tavernier M, Sarfati M, Nauwelaers F, Keenan J, Warner N, Merle-Beral H et al. (2014). Soluble CD23 (sCD23): A Forgotten Indicator of Prognosis and Identifier of Outcome in Patients with Chronic Lymphocytic Leukemia Utilizing a Novel Cba Approach. BLOOD. vol. 124,

Agrawal SG (2014). DIAGNOSIS, CLINICAL MANAGEMENT AND STEWARDSHIP FOR INVASIVE FUNGAL DISEASE IN HAEMATO-ONCOLOGY. LEUKEMIA RESEARCH. vol. 38, S10-S10.

Nannini F, Desai N, Guler S, Agrawal SG (2014). MONITORING THE INTRODUCTION OF MICAFUNGIN IN THE DEPARTMENT OF HAEMATO-ONCOLOGY AT BARTS HEALTH NHS TRUST. HAEMATOLOGICA. vol. 99, 749-749.

Mozid A, Yeo C, Arnous S, Ako E, Saunders N, Locca D, Brookman P, Archbold RA et al.(2014). Safety and feasibility of intramyocardial versus intracoronary delivery of autologous cell therapy in advanced heart failure: the REGENERATE-IHD pilot study. Regen Med vol. 9, (3) 269-278.

Renaudon-Smith E, Gribben JG, Agrawal SG(2014). Primary refractory T-cell prolymphocytic leukaemia treated with daily administration of Alemtuzumab plus high-dose methylprednisolone. Eur J Haematol vol. 92, (4) 360-361.

Hamshere S, Choudhury T, Jones DA, Locca D, Mills P, Rothman M, Knight C, Parmar M et al.(2014). A randomised double-blind control study of early intracoronary autologous bone marrow cell infusion in acute myocardial infarction (REGENERATE-AMI). BMJ Open vol. 4, (2)

Hamshere S, Choudhury T, Jones DA, Locca D, Mills P, Rothman M, Knight C, Parmar M et al.(2014). A randomised double-blind control study of early intracoronary autologous bone marrow cell infusion in acute myocardial infarction (REGENERATE-AMI). BMJ Open vol. 4, (2)

Johnson G, Ferrini A, Dolan SK, Nolan T, Agrawal S, Doyle S, Bustin SA(2014). Biomarkers for invasive aspergillosis: the challenges continue. Biomark Med vol. 8, (3) 429-451.

Johnson GL, Sarker SJ, Bustin SA, Agrawal SG(2014). Insufficient demonstration of long-term stability of Aspergillus galactomannan. Journal of Clinical Microbiology vol. 52, (11)

Farren TW, Liu F, Macey MG, Kipps TJ, Warner N, Agrawal SG (2013). Combined ROR1 and CD160 Detection For Improved Minimal Residual Disease In Patients With Chronic Lymphocytic Leukemia (CLL). BLOOD. vol. 122,

Liu F, Jia L, Wang P, Farren T, Agrawal SG (2013). Tocilizumab Overcomes Chemo-Resistance Of CLL Cells. BLOOD. vol. 122,

Gascon P, Tesch H, Verpoort K, Rosati MS, Salesi N, Agrawal S, Wilking N, Barker H et al.(2013). Clinical experience with ZarzioA (R) in Europe: what have we learned?. SUPPORTIVE CARE IN CANCER vol. 21, (10) 2925-2932.

Ferrini A, Johnson GL, Agrawal SG, Bustin SA(2013). Development of a MIQE-compliant Aspergillus terreus specific qPCR assay. MYCOSES vol. 56, 78-78.

Johnson GL, Shannon M, Thornton CR, Agrawal SG, Bustin SA(2013). Proximity ligation assay for the sensitive, specific and early diagnosis of invasive fungal disease. MYCOSES vol. 56, 48-49.

Miraki-Moud F, Anjos-Afonso F, Hodby KA, Griessinger E, Rosignoli G, Lillington D, Jia L, Davies JK et al.(2013). Acute myeloid leukemia does not deplete normal hematopoietic stem cells but induces cytopenias by impeding their differentiation. Proc Natl Acad Sci U S A vol. 110, (33) 13576-13581.

Davies JK, Taussig D, Oakervee H, Smith M, Agrawal S, Cavenagh JD, Gribben JG(2013). Long-term survival with low toxicity after allogeneic transplantation for acute myeloid leukaemia and myelodysplasia using non-myeloablative conditioning without T cell depletion. Br J Haematol vol. 162, (4) 525-529.

Johnson GL, Sarker S-J, Hill K, Tsitsikas DA, Morin A, Bustin SA, Agrawal SG(2013). Significant decline in Galactomannan Signal during storage of clinical serum samples. Int J Mol Sci vol. 14, (7) 12970-12977.

Nizam A, Heath A, Fanous M, Dark L, Agrawal S (2013). AUDIT OF POSACONAZOLE USAGE IN THE HAEMATO-ONCOLOGY UNIT AT ST BARTHOLOMEW'S HOSPITAL. HAEMATOLOGICA. vol. 98, 186-186.

Riches JC, Davies JK, McClanahan F, Fatah R, Iqbal S, Agrawal S, Ramsay AG, Gribben JG(2013). T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production. Blood vol. 121, (9) 1612-1621.

Mozid AM, Jones D, Arnous S, Saunders N, Wragg A, Martin J, Agrawal S, Mathur A(2013). The effects of age, disease state, and granulocyte colony-stimulating factor on progenitor cell count and function in patients undergoing cell therapy for cardiac disease. Stem Cells and Development vol. 22, (2) 216-223.

Gascon P, Tesch H, Verpoort K, Rosati MS, Salesi N, Barker H, Agrawal S, Muenzberg M et al. (2012). USE OF BIOSIMILAR G-CSF FOR PREVENTION OF CHEMOTHERAPY-INDUCED NEUTROPENIA: POOLED ANALYSIS OF CLINICAL USAGE STUDIES. ANNALS OF ONCOLOGY. vol. 23, 502-503.

Agrawal S, Jones B, Barnes R, Kibbler C, Millen M, Ashcroft M, Jain S, Last A et al.(2012). A practical critique of antifungal treatment guidelines for haemato-oncologists. Crit Rev Microbiol vol. 38, (3) 203-216.

Liu F, Jia L, Farren T, Gribben J, Agrawal S (2012). AUTOCRINE IL-6 PRODUCTION CORRELATED WITH SURVIVAL OF CHRONIC LYMPHOCYTIC LEUKAEMIA CELLS. HAEMATOLOGICA. vol. 97, 517-517.

Farren W, Fanous M, Liu F, Macey M, Jenner M, Agrawal S (2012). EARLY DETECTION OF MINIMAL RESIDUAL DISEASE DETECTION TARGETING CD160 IN CHRONIC LYMPHOCYTIC LEUKAEMIA PREDICTS PROGRESSION FREE SURVIVAL AND CORRELATES WITH BIOLOGICAL PROGNOSTIC RISK GROUPS. HAEMATOLOGICA. vol. 97, 291-291.

Riches J, Davies J, McClanahan F, Iqbal S, Fatah R, Agrawal S, Ramsay A, Gribben J (2012). IDENTIFICATION OF AN EXPANDED POPULATION OF TERMINALLY DIFFERENTIATED CD8+T CELLS WITH A NOVEL PHENOTYPIC AND FUNCTIONAL PROFILE IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA. HAEMATOLOGICA. vol. 97, 451-451.

Tsitsikas DA, Morin A, Araf S, Murtagh B, Johnson G, Vinnicombe S, Ellis S, Suaris T et al.(2012). Impact of the revised (2008) EORTC/MSG definitions for invasive fungal disease on the rates of diagnosis of invasive aspergillosis. Med Mycol vol. 50, (5) 538-542.

Agrawal SG, Mather SJ(2012). Pathogen identification by nuclear imaging--almost there?. Eur J Nucl Med Mol Imaging vol. 39, (7) 1173-1174.

Bustin SA, Johnson G, Agrawal SG(2012). MIQE - guidelines for developing robust real-time PCR assays. MYCOSES vol. 55, 30-30.

Auer RL, MacDougall F, Oakervee HE, Taussig D, Davies JK, Syndercombe-Court D, Agrawal S, Cavenagh JD et al.(2012). T-cell replete fludarabine/cyclophosphamide reduced intensity allogeneic stem cell transplantation for lymphoid malignancies. Br J Haematol vol. 157, (5) 580-585.

Pettitt AR, Jackson R, Carruthers S, Dodd J, Dodd S, Oates M, Johnson GG, Schuh A et al.(2012). Alemtuzumab in combination with methylprednisolone is a highly effective induction regimen for patients with chronic lymphocytic leukemia and deletion of TP53: final results of the national cancer research institute CLL206 trial. J Clin Oncol vol. 30, (14) 1647-1655.

Joshi NM, Hassan S, Jasani P, Dixon S, Cavenagh JD, Oakervee HE, Smith M, Agrawal SA et al.(2012). Bile acid malabsorption in patients with graft-versus-host disease of the gastrointestinal tract. Br J Haematol vol. 157, (3) 403-407.

Shamash J, Jacob J, Agrawal S, Powles T, Mutsvangwa K, Wilson P, Stebbing J(2012). Whole blood stem cell reinfusion and escalated dose melphalan in castration-resistant prostate cancer: a phase 1 study. Clin Cancer Res vol. 18, (8) 2352-2359.

Thornton C, Johnson G, Agrawal S(2012). Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral-flow technology. J Vis Exp (61)

Johnson GL, Bibby DF, Wong S, Agrawal SG, Bustin SA(2012). A MIQE-compliant real-time PCR assay for Aspergillus detection. PLoS One vol. 7, (7)

Liu F, Jia L, Farren TW, Gribben JG, Agrawal SG (2011). Autocrine IL-6 Production Indicates the Level of Activated STAT3 and NF-Kb of Chronic Lymphocytic Leukemia Cells. BLOOD. vol. 118, 778-778.

Farren TW, Liu F, Macey M, Jenner M, Agrawal S (2011). Early Detection of Minimal Residual Disease in Biological Prognostic Risk Groups in Chronic Lymphocytic Leukaemia (CLL) Utilizing the Novel CD160FCA Assay. BLOOD. vol. 118, 1220-1220.

Sinha S, Farren TW, Grantham M, Agrawal S (2011). The Prognostic Significance of Monoallelic Versus Biallelic 13q Deletions in Patients with Chronic Lymphocytic Leukemia. BLOOD. vol. 118, 1663-1664.

Johnson GL, Hill K, Agrawal S(2011). Decline in detectable galactomannan levels during storage of serum samples. MYCOSES vol. 54, 53-53.

Johnson GL, Bibby D, Bustin S, Thornton C, Agrawal S(2011). Detection of Aspergillus in broncho-alveolar lavage fluid using two biological assays; evidence of active infection?. MYCOSES vol. 54, 130-131.

Agrawal SG(2011). ECIL vs. IDSA guidelines. MYCOSES vol. 54, 41-42.

Farren TW, Giustiniani J, Liu F-T, Tsitsikas DA, Macey MG, Cavenagh JD, Oakervee HE, Taussig D et al.(2011). Differential and tumor-specific expression of CD160 in B-cell malignancies. Blood vol. 118, (8) 2174-2183.

Mozid A, Arnous S, Yeo C, Brookman P, Preston M, Archbold A, Rothman M, Agrawal S et al.(2011). Head-to-head comparison of different delivery methods of autologous bone marrow progenitor cells in chronic ischaemic heart failure. EUROPEAN HEART JOURNAL vol. 32, 456-456.

Shamash J, Jacob J, Powles T, Agrawal S, Mutsvangwa K, Saunders N, Wilson P, Stebbing J(2011). Melphalan and whole-blood stem cell reinfusion in castration-resistant prostate cancer (CRPC): A phase I/II study. J Clin Oncol vol. 29, (15_suppl)

Farren TW, Liu F, Macey MG, Jenner M, Prentice A, Nathwani A, Agrawal SG (2011). CD160: a novel approach to minimal residual disease (MRD) assessment in chronic lymphocytic leukaemia (CLL). BRITISH JOURNAL OF HAEMATOLOGY. vol. 153, 72-72.

Johnson G, Bustin SA, Agrawal S (2011). Efficient detection of Aspergillus DNA from broncho-alveolar lavage fluid of infected acute leukaemia patients. BRITISH JOURNAL OF HAEMATOLOGY. vol. 153, 56-56.

Powles T, Chowdhury S, Shamash J, Bazeos A, Gillessen S, Saunders N, Lim L, Sarwar N et al.(2011). Increased haematopoietic progenitor cells are associated with poor outcome in patients with metastatic renal cancer treated with sunitinib. Ann Oncol vol. 22, (4) 815-820.

Agrawal S, Hope W, Sinkó J, Kibbler C(2011). Optimizing management of invasive mould diseases. J Antimicrob Chemother vol. 66 Suppl 1, i45-i53.

Riches JC, Davies J, Iqbal S, Fatah R, Agrawal S, Ramsay AG, Gribben JG (2011). T-cells from Patients With CLL Exhibit Phenotypic and Transcription Factor Profiles Of Exhaustion Independent of CMV Serostatus. Blood. vol. 118, 1780-1783.

Tsitsikas DA, Sibony DW, Oakervee HE, Agrawal SG, Smith M, Taussig DC, de Vos J, Stewart E et al. (2010). A Phase II Trial of Sequential Treatment with Cytoreductive Therapy and Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukaemia, High Risk MDS and Other High Risk Myeoid Malignancies An Interim Report. BLOOD. vol. 116, 1430-1430.

Tsitsikas DA, Warcel-Sibony D, Oakervee HE, Agrawal SG, Smith M, Taussig DC, de Vos J, Stewart E et al. (2010). A Phase II Trial of Sequential Treatment with Cytoreductive Therapy and Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukaemia, High-Risk MDS and Other High Risk Myeoid Malignancies: An Interim Report. BLOOD. vol. 116, 1430-1430.

Liu F, Jia L, Farren T, Gribben JG, Agrawal S (2010). Autocrine IL6/STAT3 Signaling Enhances Survival of Chronic Lymphocytic Leukaemia Cells. BLOOD. vol. 116, 1481-1481.

Farren T, Liu FT, Stephens C, Macey M, Jenner M, Prentice A, Nathwani A, Agrawal S (2010). Inter Laboratory Assessment of Minimal Residual Disease In Chronic Lymphocytic Leukemia - Evaluation of the Novel CD160FCA Assay. BLOOD. vol. 116, 1122-1123.

Farren T, Liu FT, Stephens C, Macey M, Jenner M, Prentice A, Nathwani A, Agrawal S (2010). Inter-Laboratory Assessment of Minimal Residual Disease In Chronic Lymphocytic Leukemia-7 Evaluation of the Novel CD160FCA Assay. BLOOD. vol. 116, 1122-1123.

Tsitsikas DA, Vinicombe S, Sheaff M, Ellis S, Rizvi H, Manuel R, Agrawal SG(2010). A patient with CLL and a dry cough. BMJ vol. 340,

Chowdhury S, O'Brien TS, Sarwar N, Shamash J, McGrath S, Agrawal S, Lim L, Rudman SM et al.(2010). The effect of sunitinib on immune parameters and haemopoetic stem cell markers in patients with untreated cleat cell renal cancer. JOURNAL OF CLINICAL ONCOLOGY vol. 28, (15)

Liu F-T, Giustiniani J, Farren T, Jia L, Bensussan A, Gribben JG, Agrawal SG(2010). CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia. Blood vol. 115, (15) 3079-3088.

Taussig DC, Vargaftig J, Miraki-Moud F, Griessinger E, Sharrock K, Luke T, Lillington D, Oakervee H et al.(2010). Leukemia-initiating cells from some acute myeloid leukemia patients with mutated nucleophosmin reside in the CD34(-) fraction. Blood vol. 115, (10) 1976-1984.

Macey MG, Bevan S, Alam S, Verghese L, Agrawal S, Beski S, Thuraisingham R, MacCallum PK(2010). Platelet activation and endogenous thrombin potential in pre-eclampsia. Thromb Res vol. 125, (3) e76-e81.

Lambourne J, Agranoff D, Herbrecht R, Troke PF, Buchbinder A, Willis F, Letscher-Bru V, Agrawal S et al.(2009). Association of mannose-binding lectin deficiency with acute invasive aspergillosis in immunocompromised patients. Clin Infect Dis vol. 49, (10) 1486-1491.

Yeo C, Locca D, Wong J, Burchell T, Preston M, Brookman P, Hipperson D, Archbold A et al. (2009). Ejection Fraction and NYHA Class in Heart Failure in the REGENERATE-IHD Stem Cell Study: a Comparison Between the Intramyocardial and Intracoronary Arms. AMERICAN JOURNAL OF CARDIOLOGY. vol. 104, 190D-191D.

Yeo C, Saunders N, Locca D, Flett A, Preston M, Brookman P, Davy B, Mathur A et al.(2009). Ficoll-Paque (TM) versus Lymphoprep (TM): a comparative study of two density gradient media for therapeutic bone marrow mononuclear cell preparations. REGEN MED vol. 4, (5) 689-696.

Tsitsikas DA, Oakervee H, Cavenagh JD, Gribben J, Agrawal SG, Mattes FM(2009). Treatment of respiratory syncytial virus infection in haemopoietic stem cell transplant recipients with aerosolized ribavirin and the humanized monoclonal antibody palivizumab: a single centre experience. Br J Haematol vol. 146, (5) 574-576.

Matin RN, Agrawal SG, Jenner M, Cerio R, Rizvi H, Harwood CA (2009). Splenic B-cell marginal zone lymphoma presenting in the skin. BRITISH JOURNAL OF DERMATOLOGY. vol. 161, 89-89.

Yeo C, Locca D, Wong J, Saunders N, Preston M, Brookman T, Archbold A, Rothman M et al. (2009). EJECTION FRACTION AND NYHA CLASS IN HEART FAILURE IN THE REGENERATE-IHD STEM CELL STUDY: A COMPARISON BETWEEN THE INTRAMYOCARDIAL AND INTRACORONARY ARMS. HEART. vol. 95, A70-A70.

Hassan S, Leung M, Ridler C, Stephens C, Macey M, Jenner M, Agrawal S (2009). FLT3 ANTIGEN EXPRESSION IN ACUTE LEUKAEMIA USING FLOW CYTOMETRY. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. vol. 94, 117-117.

Pettitt R, Matutes E, Dearden C, Oscier D, Carruthers S, Dodd J, Dodd S, Jones R et al. (2009). RESULTS OF THE PHASE II NCRI CLL206 TRIAL OF ALEMTUZUMAB IN COMBINATION WITH HIGH-DOSE METHYLPREDNISOLONE FOR HIGH-RISK (17P-) CLL. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. vol. 94, 138-139.

Tsitsikas DA, Morin A, Murtagh B, Athorn G, Suaris T, Ellis S, Vinnicombe S, Wilks M et al. (2009). Significant reduction in the diagnosis of possible and probable invasive fungal infection by applying the revised EORTC definitions of invasive fungal disease. BONE MARROW TRANSPLANTATION. vol. 43, S46-S46.

Tsitsikas DA, Oakervee H, Cavenagh J, Agrawal S, Gribben J, Mattes F (2009). Treatment of respiratory syncytial virus infection with nebulised ribavirin and the humanised monoclonal antibody palivizumab in eight haemopoietic stem cell transplant recipients. BONE MARROW TRANSPLANTATION. vol. 43, S252-S253.

Agrawal SG, Liu FT, Giustiniani J, Jia L, Gribben JG, Bensussan A (2008). Dual Action of CD160 on CLL Cells: Giving Life to Prepare for Death!. BLOOD. vol. 112, 726-726.

Liu F-T, Agrawal SG, Movasaghi Z, Wyatt PB, Rehman IU, Gribben JG, Newland AC, Jia L(2008). Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib. Blood vol. 112, (9) 3835-3846.

Taussig DC, Miraki-Moud F, Anjos-Afonso F, Pearce DJ, Allen K, Ridler C, Lillington D, Oakervee H et al.(2008). Anti-CD38 antibody-mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells. Blood vol. 112, (3) 568-575.

Malyszczak W, Jones BL, Jackson B, Malyszczak W, Agrawal S, Jensen M (2008). COST COMPARISON OF LIPOSOMAL AMPHOTERICIN B VS CASPOFUNGIN FOR THE EMPIRICAL TREATMENT OF INVASIVE FUNGAL INFECTIONS. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. vol. 93, 321-321.

Khanna P, Doffman S, Griffiths L, Wareham D, Agrawal SG, Das S(2008). A case of febrile nelitropenia with a skin rash. J INFECTION vol. 56, (4) 309-309.

Bevan S, Beski S, Thuraisingham R, Agrawal S, Barnes I, Alam S, Verghese L (2008). Preeclampsia - risk assessment. BRITISH JOURNAL OF HAEMATOLOGY. vol. 141, 64-64.

Bevan S, Beski S, Thuraisingham R, Agrawal S, Barnes I, Alam S, Verghese L (2008). The endogenous thrombin potential has high positive predictive value for recurrent unprovoked venous thrombosis in the second Cambridge prospective cohort study. BRITISH JOURNAL OF HAEMATOLOGY. vol. 141, 64-65.

Liu F-T, Agrawal SG, Gribben JG, Ye H, Du M-Q, Newland AC, Jia L(2008). Bortezomib blocks Bax degradation in malignant B cells during treatment with TRAIL. Blood vol. 111, (5) 2797-2805.

Agrawal SG, Liu F-T, Wiseman C, Shirali S, Liu H, Lillington D, Du M-Q, Syndercombe-Court D et al.(2008). Increased proteasomal degradation of Bax is a common feature of poor prognosis chronic lymphocytic leukemia. Blood vol. 111, (5) 2790-2796.

Davies CEF, Whitelocke RAF, Agrawal S(2008). Retinal complications associated with hyperviscosity in chronic lymphocytic leukaemia. INTERN MED J vol. 38, (2)

Doffman SR, Griffiths LJ, Athorn GR, Vinnicombe SJ, Moore-Gillon JC, Griffiths MJ, Agrawal SG (2007). Galactomannan detection in exhaled breath condensate of neutropenic patients with suspected invasive pulmonary aspergillosis. THORAX. vol. 62, A50-A51.

Greaves P, Agrawal S(2007). Safe and efficacious use of recombinant human erythropoietin in malignancy. Clin Med (Lond) vol. 7, (6) 617-620.

Thorogood N, Atwal S, Mills W, Jenner M, Lewis DA, Cavenagh JD, Agrawal SG(2007). The risk of antimalarials in patients with renal failure. POSTGRAD MED J vol. 83, (986) Article e8,

Doffman SR, Griffiths LJ, Lim C, Vinnicombe S, Wilks M, Gribben JG, Griffiths MJ, Agrawal SG (2007). A novel non-invasive method of detecting galactomannan in suspected pulmonary aspergillosis. BLOOD. vol. 110, 33B-33B.

Agrawal SG, Liu FT, Wiseman C, Shirali S, Liu H, Lillington D, Du MQ, Court DS et al. (2007). Bax degradation activity is a novel poor prognosis marker of chronic lymphocytic leukemia. BLOOD. vol. 110, 908A-908A.

Giustiniani J, Wiseman C, Farren T, Gribben JG, Agrawal SG (2007). CLL cell proliferation and IL-6 production are regulated by CD160-MHC class I interactions offering new therapeutic targets. BLOOD. vol. 110, 342A-342A.

Wiseman C, Giustiniani J, Mikkelsen L, Macey M, Goff L, Gribben J, Agrawal S (2007). High frequency of surface immunoglobulin IgG in B-Cell chronic lymphocytic leukaemia. BLOOD. vol. 110, 245B-245B.

Tsitsikas DA, Giustiniani J, Skipper A, Ebrahim F, Johannson U, Macey M, Jenner M, Newland AC et al. (2007). Universal CD160 expression and the CD5+23+/CD5+19+ ratio in chronic lymphocytic leukemia simpify identification of atypical cases from CD23+ mantle cell lymphoma. BLOOD. vol. 110, 243B-243B.

Farren T, Giustiniani J, Johansson U, Lim C, Athorn G, Newland A, Macey M, Agrawal S (2007). Using CD160 as a novel approach to the assessment of minimal residual disease (MRD) in chronic lymphocytic leukaemia (CLL). BLOOD. vol. 110, 606A-606A.

AGRAWAL SG, Currie C, Poole C(2007). Let cost effectiveness models be open to scrutiny. BMJ vol. 335,

Greaves P, Agrawal S, Lim C, Poole C (2007). Intravenous iron improves response rates to recombinant human erythropoietin in anaemic patients with haematological malignancy on chemotherapy which iron parameters to use?. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. vol. 92, 28-28.

Agrawal SG, Greaves P, Lim C, Poole CD, Walker MD (2006). Optimising haemoglobin response to exogenous erythropoietin in anaemic patients treated in routine haemato-oncology practice. BLOOD. vol. 108, 476B-476B.

Dulic-Sills A, Blunden MJ, Mawdsley J, Bastin AJ, McAuley D, Griffiths M, Rampton DS, Yaqoob MM et al.(2006). New flow cytometric technique for the evaluation of circulating endothelial progenitor cell levels in various disease groups. Journal of Immunological Methods vol. 316, (1-2) 107-115.

Dulic-Sills A, Blunden MJ, Mawdsley J, Bastin AJ, McAuley D, Griffiths M, Rampton DS, Yaqoob MM et al.(2006). New flow cytometric technique for the evaluation of circulating endothelial progenitor cell levels in various disease groups. J Immunol Methods vol. 316, (1-2) 107-115.

Agrawal S, Davidson N, Walker M, Gibson S, Lim C, Morgan CL, Cowell W(2006). Assessing the total costs of blood delivery to hospital oncology and haematology patients. Curr Med Res Opin vol. 22, (10) 1903-1909.

Griffiths LJ, Anyim M, Doffman SR, Wilks M, Millar MR, Agrawal SG(2006). Comparison of DNA extraction methods for Aspergillus fumigatus using real-time PCR. J Med Microbiol vol. 55, (Pt 9) 1187-1191.

Davies JK, Taussig DC, Oakervee H, Davies AJ, AGRAWAL SG, Gribben JG, Lister TA, Cavenagh JD(2006). Long-Term Follow-Up After Reduced-Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia/Myelodysplastic Syndrome: Late CNS Relapses Despite Graft-Versus-Host Disease. Journal of Clinical Oncology vol. 24, 23e-25.

Quint J, Mills W, Lewis D, Cavenagh JD, Agrawal SG(2006). A complication of steroid therapy in acute leukaemia--a case report. Hematology vol. 11, (2) 97-99.

Ansari N, Popat R, Lim C, Cavill I, Agrawal SG (2006). High response rates to erythropoietin therapy for chemotherapy-associated anaemia using targeted intravenous iron supplementation. BRITISH JOURNAL OF HAEMATOLOGY. vol. 133, 34-35.

Popat R, Oakervee H, Curry N, Foot N, Morris C, Drake M, Agrawal S, Odeh L et al. (2006). Low dose PAD combination therapy (PS-341/bortezomib, adriamycin and dexamethasone) for untreated multiple myeloma. BRITISH JOURNAL OF HAEMATOLOGY. vol. 133, 99-99.

Popat R, Oakervee HE, Foot N, Agrawal S, Odeh L, Craddock C, Williams C, Basu S et al. (2006). Low dose intravenous melphalan and bortezomib for relapsed multiple myeloma. BRITISH JOURNAL OF HAEMATOLOGY. vol. 133, 98-98.

Mills KI, Walsh V, Gilkes AF, Agrawal SG, Knapper S(2006). Novel observation of three FLT3 codons mutated in tandem in an elderly acute myeloid leukaemia patient (vol 132, pg 116, 2006). BRITISH JOURNAL OF HAEMATOLOGY vol. 132, (5) 663-663.

Mills KI, Walsh V, Gilkes AF, Agrawal SG, Knapperb S(2006). Novel observation of three FLT3 codons mutated in tandem in an elderly acute myeloid leukaemia patient. BRIT J HAEMATOL vol. 132, (1) 116-117.

Popat R, Oakervee HE, Foot N, Agrawal S, Smith P, Craddock C, Williams C, Basu S et al. (2005). A phase I/II study of bortezomib and low dose intravenous melphalan (BM) for relapsed multiple myeloma. BLOOD. vol. 106, 718A-718A.

Agrawal SG, Lim C, Cavill I (2005). Prospective targeted epoietin beta therapy for chemotherapy-associated anaemia achieves high response rates. BLOOD. vol. 106, 175A-175A.

Popat R, Oakervee HE, Curry N, Foot N, Morris C, Drake M, Agrawal S, Smith P et al. (2005). Reduced dose PAD combination therapy (PS-341/bortezomib, adriamycin and dexamethasone) for previously untreated patients with multiple myeloma. BLOOD. vol. 106, 717A-718A.

Blunden MJ, Dulic-Sills A, Yaqoob MM, Agrawal S, Macey MG (2005). Endothelial progenator cells are reduced in patients with chronic kidney disease, especailly those with pre-existing cardiovascular disease, compared to healthy individuals. CYTOMETRY PART B-CLINICAL CYTOMETRY. vol. 68B, 54-55.

AGRAWAL SG, Doffman SR, Brown JS(2005). Invasive pulmonary aspergillosis. Expert Rev Anti Infect Ther, 2005 vol. 3, 613-27.

Oakervee HE, Popat R, Curry N, Smith P, Morris C, Drake M, Agrawal S, Stec J et al.(2005). PAD combination therapy (PS-341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myeloma. BRIT J HAEMATOL vol. 129, (6) 755-762.

Popat R, Oakervee HE, Agrawal S, Smith P, Singer C, Craddock C, Williams C, Wylde P et al. (2005). A phase I/II trial of bortezomib and low dose intravenous melphalan (BM) for relapsed multiple myeloma. BRITISH JOURNAL OF HAEMATOLOGY. vol. 129, 27-27.

Popat R, Oakervee H, Foot N, Curry N, Morris C, Drake M, Agrawal S, Smith P et al. (2005). PAD (PS-341/bortezomib, adriamycin and dexamethasone) as front-line therapy for untreated patients with multiple myeloma. BRITISH JOURNAL OF HAEMATOLOGY. vol. 129, 22-22.

Rintala T, Agrawal S, Cavenagh J, Barts DM (2005). "Many are called, few are chosen". BONE MARROW TRANSPLANTATION. vol. 35, S324-S325.

Rintala T, Ritchie L, Goodwin S, Delgado-Gonzalez J, Agrawal S (2005). Allogeneic donor safety: addressing JACIE. BONE MARROW TRANSPLANTATION. vol. 35, S288-S289.

Petrie JA, Milne T, Ridler C, Cavenagh JD, Agrawal SG (2004). CD123 expression in chronic lymphocytic leukaemia - Strong correlation with ZAP70 and CD38 expression. BLOOD. vol. 104, 185B-185B.

Ridler C, Smith M, Milne T, Ebrahim F, Macey M, Lister TA, Fitzgibbon J, Cavenagh JD et al. (2004). Flow cytometric FLT3 expression in acute leukaemias is of diagnostic value but does not correlate with ITD/D835Y mutation status. BLOOD. vol. 104, 823A-823A.

Petrie JA, Milne T, Ebrahim F, Cavenagh JD, Agrawal SG (2004). Incidence of ZAP70 positivity in fresh samples from unselected patients presenting with a B-cell lymphoproliferative disorder. BLOOD. vol. 104, 183B-184B.

Cavenagh JD, Popat R, Curry N, Stec J, Morris TC, Drake M, Agrawal S, Smith P et al. (2004). PAD combination therapy (PS-341/bortezomib, adriamycin and dexamethasone) for previously untreated patients with multiple myeloma. BLOOD. vol. 104, 413A-413A.

Cavenagh JD, Curry N, Stec J, Drake M, Morris TC, Agrawal S, Esseltine D, Schenkein D et al.(2004). PAD therapy (bortezomib, doxorubicin and dexamethasone) for untreated multiple myeloma (MM). J Clin Oncol vol. 22, (14_suppl)

McCloskey D, Rintala T, Agrawal S, Murrell C, Gupta A, Hemmatapour S, Sinnott P, Cavenagh J (2004). Improving probabilities of identifying a matched family donor: the use of 'vertical' HLA typing. BONE MARROW TRANSPLANTATION. vol. 33, S134-S134.

Feng WY, Liu FT, Patwari Y, Agrawal SG, Newland AC, Jia L(2003). BH3-domain mimetic compound BH3I-2 ' induces rapid damage to the inner mitochondrial membrane prior to the cytochrome c release from mitochondria. BRIT J HAEMATOL vol. 121, (2) 332-340.

Jia L, Patwari Y, Kelsey SM, Srinivasula SM, Agrawal SG, Alnemri ES, Newland AC(2003). Role of Smac in human leukaemic cell apoptosis and proliferation. ONCOGENE vol. 22, (11) 1589-1599.

Agrawal SG, Milne TM, Marquet J, Platton SJ, Wilkes SJ, Cavenagh JD, Feng TL, Amess J et al. (2002). CD160 expression in low grade B-cell lymphoproliferative disorders. BLOOD. vol. 100, 384A-384A.

AGRAWAL SG, Gaulard P, Delfau-Larue MH, Rouard H, Farcet JP, Bensussan A, Reyes F, Boumsell L et al.(2001). Multiple co-stimulatory signals are required for triggering proliferation of T cells from human secondary lymphoid tissue. Int. Immunol vol. 13, (4) 441-450.